Free Trial

Citius Pharmaceuticals (CTXR) SEC Filings & 10K Form

Citius Pharmaceuticals logo
$0.70 -0.02 (-2.90%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 +0.02 (+2.84%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Citius Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/28/2025
6:30 AM
Citius Pharmaceuticals (Filer)
Form DEF 14A
04/28/2025
6:32 AM
Citius Pharmaceuticals (Filer)
Form DEFA14A
04/02/2025
6:27 AM
Citius Pharmaceuticals (Filer)
Form 424B5
03/10/2025
3:30 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM
Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:20 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:05 PM
Citius Pharmaceuticals (Filer)
Form DEF 14A
01/27/2025
3:07 PM
Citius Pharmaceuticals (Filer)
Form DEFA14A
01/16/2025
3:30 PM
Citius Pharmaceuticals (Filer)
Form PRE 14A
01/08/2025
3:05 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
8:00 AM
Citius Pharmaceuticals (Filer)
Form 424B5
01/07/2025
8:11 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM
Citius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2024
3:30 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:05 PM
Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
Form SC 13D/A
11/25/2024
4:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:30 AM
Citius Pharmaceuticals (Filer)
Form 424B5
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:25 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:26 PM
Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:27 PM
Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
7:30 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:26 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM
Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:01 PM
Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:34 PM
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
Form SC 13D
08/16/2024
3:35 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
5:19 PM
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:25 PM
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:10 PM
Citius Pharmaceuticals (Filer)
Form 424B5
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
08/12/2024
4:25 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:51 PM
Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:20 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTXR) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners